Seres Therapeutics Inc (NAS:MCRB)
$ 0.7882 0.0123 (1.59%) Market Cap: 119.37 Mil Enterprise Value: 221.04 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Seres Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 04:15PM GMT
Release Date Price: $3.07 (-4.95%)
Unidentified Analyst

I'm just going to read the research disclosure first. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Good afternoon, Eric and Terri. I'm very happy to have you here today. And before we dive in, I would be remiss in terms of a hearty congratulations in terms of product approval, no small feat, and a successful launch, and we'll be hearing a lot about that.

But before we dive into VOWST, perhaps you'd like to give a little bit of background in terms of the vision of Seres and bringing oral microbiome therapeutics to the marketplace.

Questions & Answers

Eric D. Shaff
Seres Therapeutics, Inc. - President, CEO & Director

Sure. And before I begin, I just want to thank you, Jessica, and Morgan Stanley, for having us here today. And we think it's a great time to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot